Shares of Compass Minerals International, Inc. CMP fell sharply during Thursday’s session following downbeat results.
Compass Minerals Intl posted quarterly adjusted earnings of 5 cents per share, missing market estimates of 26 cents per share. The company’s quarterly sales came in at $341.70 million versus expectations of $357.90 million.
Compass Minerals International shares fell 9% to $20.52 on Thursday.
Here are some other stocks moving in today’s mid-day session.
Winners
- Syra Health Corp. SYRA shares jumped 310% to $4.71 after the company announced a partnership for a federal contract valued at $75 billion.
- Healthcare Triangle, Inc. HCTI surged 36% to $3.8250.
- MicroCloud Hologram Inc. HOLO gained 15% to $20.70 after surging 1,100% on Wednesday. The company announced it planned to join the Communications Industry Association.
- The Walt Disney Company DIS rose 9.5% to $108.54 after the company reported better-than-expected earnings for its first quarter and declared a cash dividend of 45 cents per share. The company announced a new share repurchase program and said it expects fiscal 2024 earnings of roughly $4.60 per share. Disney also announced a $1.5 billion investment in leading video game company Epic Games.
Market Watch: Fluctuations in Stock Prices
Winners
- SPB gained 9% to $87.18 following better-than-expected quarterly earnings.
- EverQuote, Inc. gained 8.3% to $14.57. EverQuote is expected to report fourth quarter financial results after the market close on Feb. 26, 2024.
Losers
- Tenax Therapeutics, Inc. shares fell 64.4% to $5.08 after the company announced the pricing of its $9 million public offering.
- Bakkt Holdings, Inc. fell 34.8% to $0.9442.
- Phoenix Biotech Acquisition Corp. fell 32.7% to $4.7272.
- Yield10 Bioscience, Inc. fell 29.7% to $0.26 after the company provided an update on its Omega-3 Camelina program.
- Cadrenal Therapeutics, Inc. declined 28% to $0.8147. Cadrenal Therapeutics named Jeff Cole as Chief Operating Officer in advance of Tecarfarin Phase 3 pivotal trial.
- Solidion Technology Inc. fell 24.6% to $1.32.
- Dynatronics Corporation dipped 24.4% to $0.5121.
- MariaDB plc shares fell 23.4% to $0.36 after gaining around 95% on Wednesday.
- 23andMe Holding Co. fell 22.7% to $0.56 after the company reported worse-than-expected third-quarter financial results and issued FY24 revenue guidance below estimates.
- Digital Turbine, Inc. shares dipped 20% to $4.03 after the company reported worse-than-expected third-quarter financial results.
- Insperity, Inc. fell 19.4% to $91.12 following quarterly results.
- Lightspeed Commerce Inc. declined 19.4% to $15.78 after the company reported third-quarter financial results.
- Lumentum Holdings Inc. fell 16.3% to $49.21 following quarterly results.
- GoPro, Inc. shares fell 12.9% to $2.5250 following weak sales for the fourth quarter.
- Mangoceuticals, Inc. shares dipped 11.4% to $0.3650 after falling 8% on Wednesday.
- Everest Group, Ltd. fell 10.4% to $344.20 after the company reported mixed fourth-quarter financial results.
- PayPal Holdings, Inc. shares declined 10.3% to $56.67. PayPal reported upbeat earnings and sales results for its fourth quarter on Wednesday. However, the company said it expects full-year 2024 adjusted earnings to be in line with full-year 2023 earnings of $5.10 per share.
- Envista Holdings Corporation fell 10% to $21.81 following weak earnings.
- Axcelis Technologies, Inc. shares tumbled 9.5% to $119.06 after the company reported fourth-quarter financial results.
- TruGolf Holdings, Inc. shares fell 9.3% to $1.65 after climbing over 18% on Wednesday.
- NETGEAR, Inc. declined 8.6% to $13.08. NETGEAR said it expects first-quarter net revenue of $155 million to $170 million.
- BorgWarner Inc. fell 8.4% to $30.98 after it reported fourth-quarter results.
- CalAmp Corp. fell 7.8% to $2.36 after dipping 11% on Wednesday.
- Snap-on Incorporated fell 7.6% to $272.12 following fourth-quarter results.
- ThermoGenesis Holdings, Inc. shares declined 7% to $0.78 after jumping over 42% on Wednesday.
- AstraZeneca PLC fell 5.8% to $62.68 after the company reported worse-than-expected quarterly financial results.
Now Read This: Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
